ブルガダ症候群の世界市場は、2021年に約13億2,000万米ドルと評価され、予測期間の2022年から2029年には6.5%を超える成長率で成長すると予測されています。
ブルガダ症候群は、電気信号が心臓を通過する方法に影響を与えるまれな遺伝性疾患です。常染色体優性遺伝病であり、片方の親からだけ遺伝する可能性があります。ブルガダ症候群は、心臓の正常なリズムに乱れを生じさせます。めまい、失神、あえぎ、呼吸困難、不整脈、動悸、極端に速い不整脈などの症状があります。心臓関連疾患の発生率の増加、ブルガダ症候群の有病率の増加、および主要な市場関係者による戦略的な取り組みが、市場の成長を加速させる主な要因となっています。
世界保健機関（WHO）の推計によると、2019年現在、世界的に約1,790万人がCVDによって命を落とし、世界の全死亡者の32％以上を目撃しています。また、CVDに関連する死亡の約85%は心臓発作や脳卒中が原因となっています。さらに、2019年のThe National Organization for Rare Disordersによると、アメリカにおけるブルガダ症候群の有病率は10,000人に5人と推定されています。また、遺伝的症候群の認知度の上昇と医薬品およびバイオテクノロジー産業の成長は、予測期間中に市場の有利な成長見通しを生み出すでしょう。しかし、ブルガダ症候群に関連する高い治療費は、2022年から2029年の予測期間を通じて市場の成長を阻害します。
世界のブルガダ症候群市場調査のために考慮された主要地域は、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、世界のその他の地域が含まれます。北アメリカは、主要な市場プレイヤーの存在や、確立されたヘルスケアインフラの利用可能性などの要因により、市場シェアの面で主要な地域となっています。一方、アジア太平洋地域は、ブルガダ症候群の有病率の上昇や医療インフラの整備などの要因により、予測期間中に最も高いCAGRで成長すると予想されています。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Brugada Syndrome Market, by Region, 2019-2029 (USD Billion)
1.2.2. Brugada Syndrome Market, by Diagnosis, 2019-2029 (USD Billion)
1.2.3. Brugada Syndrome Market, by Treatment, 2019-2029 (USD Billion)
1.2.4. Brugada Syndrome Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Brugada Syndrome Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Brugada Syndrome Market Dynamics
3.1. Brugada Syndrome Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of heart-related diseases.
3.1.1.2. Growing prevalence of Brugada Syndrome.
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High treatment cost associated with Brugada Syndrome.
3.1.2.2. Unfavourable reimbursement scenarios.
3.1.3. Market Opportunities
3.1.3.1. Rising awareness of genetic syndromes.
3.1.3.2. Growing pharmaceuticals & biotechnology industry.
Chapter 4. Global Brugada Syndrome Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Brugada Syndrome Market, by Diagnosis
6.1. Market Snapshot
6.2. Global Brugada Syndrome Market by Diagnosis, Performance - Potential Analysis
6.3. Global Brugada Syndrome Market Estimates & Forecasts by Diagnosis 2019-2029 (USD Billion)
6.4. Brugada Syndrome Market, Sub Segment Analysis
6.4.1. Electrocardiogram
6.4.2. Electrophysiology (EP) Test
6.4.3. Genetic Testing
6.4.4. Others
Chapter 7. Global Brugada Syndrome Market, by Treatment
7.1. Market Snapshot
7.2. Global Brugada Syndrome Market by Treatment, Performance - Potential Analysis
7.3. Global Brugada Syndrome Market Estimates & Forecasts by Treatment 2019-2029 (USD Billion)
7.4. Brugada Syndrome Market, Sub Segment Analysis
7.4.1. Implantable Cardioverter-Defibrillator
7.4.2. Drug Therapy
Chapter 8. Global Brugada Syndrome Market, by End User
8.1. Market Snapshot
8.2. Global Brugada Syndrome Market by End User, Performance - Potential Analysis
8.3. Global Brugada Syndrome Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Brugada Syndrome Market, Sub Segment Analysis
8.4.1. Hospitals and Clinics
8.4.2. Surgical Centers
8.4.3. Diagnostic Centers
8.4.4. Others
Chapter 9. Global Brugada Syndrome Market, Regional Analysis
9.1. Brugada Syndrome Market, Regional Market Snapshot
9.2. North America Brugada Syndrome Market
9.2.1. U.S. Brugada Syndrome Market
9.2.1.1. Diagnosis breakdown estimates & forecasts, 2019-2029
9.2.1.2. Treatment breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Brugada Syndrome Market
9.3. Europe Brugada Syndrome Market Snapshot
9.3.1. U.K. Brugada Syndrome Market
9.3.2. Germany Brugada Syndrome Market
9.3.3. France Brugada Syndrome Market
9.3.4. Spain Brugada Syndrome Market
9.3.5. Italy Brugada Syndrome Market
9.3.6. Rest of Europe Brugada Syndrome Market
9.4. Asia-Pacific Brugada Syndrome Market Snapshot
9.4.1. China Brugada Syndrome Market
9.4.2. India Brugada Syndrome Market
9.4.3. Japan Brugada Syndrome Market
9.4.4. Australia Brugada Syndrome Market
9.4.5. South Korea Brugada Syndrome Market
9.4.6. Rest of Asia Pacific Brugada Syndrome Market
9.5. Latin America Brugada Syndrome Market Snapshot
9.5.1. Brazil Brugada Syndrome Market
9.5.2. Mexico Brugada Syndrome Market
9.6. Rest of The World Brugada Syndrome Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Novartis AG
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. F. Hoffmann-La Roche Ltd
10.2.3. Boehringer Ingelheim International GmbH.
10.2.4. Pfizer Inc.
10.2.5. Ionis Pharmaceuticals Inc.
10.2.6. Abbott
10.2.7. Novo Nordisk A/S
10.2.8. Takeda Pharmaceutical Company Limited.
10.2.9. AstraZeneca
10.2.10. Cytokinetics, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Brugada Syndrome Market, report scope
TABLE 2. Global Brugada Syndrome Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Brugada Syndrome Market estimates & forecasts by Diagnosis 2019-2029 (USD Billion)
TABLE 4. Global Brugada Syndrome Market estimates & forecasts by Treatment 2019-2029 (USD Billion)
TABLE 5. Global Brugada Syndrome Market estimates & forecasts by End User 2019-2029 (USD Billion)
TABLE 6. Global Brugada Syndrome Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Brugada Syndrome Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Brugada Syndrome Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Brugada Syndrome Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Brugada Syndrome Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Brugada Syndrome Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Brugada Syndrome Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Brugada Syndrome Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Brugada Syndrome Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Brugada Syndrome Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Brugada Syndrome Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Brugada Syndrome Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Brugada Syndrome Market
TABLE 71. List of primary sources, used in the study of global Brugada Syndrome Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Brugada Syndrome Market, research methodology
FIG 2. Global Brugada Syndrome Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Brugada Syndrome Market, key trends 2021
FIG 5. Global Brugada Syndrome Market, growth prospects 2022-2029
FIG 6. Global Brugada Syndrome Market, porters 5 force model
FIG 7. Global Brugada Syndrome Market, pest analysis
FIG 8. Global Brugada Syndrome Market, value chain analysis
FIG 9. Global Brugada Syndrome Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Brugada Syndrome Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Brugada Syndrome Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Brugada Syndrome Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Brugada Syndrome Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Brugada Syndrome Market, regional snapshot 2019 & 2029
FIG 15. North America Brugada Syndrome Market 2019 & 2029 (USD Billion)
FIG 16. Europe Brugada Syndrome Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Brugada Syndrome Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Brugada Syndrome Market 2019 & 2029 (USD Billion)
FIG 19. Global Brugada Syndrome Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
